Form 4 for MRNA Moderna
Accepted 2022-12-09 00:00:00 ET · period of report 2022-12-07 · accession 0001127602-22-027176 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-12-09 | 2022-12-07 | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | $0.00 | +1,139 | 5,262 | +28% | $0 |
| D | 2022-12-09 | 2022-12-08 | MRNA | Klinger Shannon Thyme | CLO | S - Sale+OE | $179.15 | -490 | 4,772 | -9% | -$87.8K |
| D | 2022-12-09 | 2022-12-07 | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | $0.00 | -1,139 | 11.4K | -9% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-07 | M | A | 1,139 | $0.00 | 5,262 | D | — | — | (F2) Includes 174 shares acquired under the Moderna, Inc. 2018 Employee Stock Purchase Plan on November 30, 2022. |
| 2 | Common | Common Stock | 2022-12-08 | S | D | 490 | $179.15 | 4,772 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2022-12-07 | M | D | 1,139 | $0.00 | 11,386 | D | $0.00 · 2022-06-07 to — | 1,139 Common Stock | (F4) 25% of the shares subject to this restricted stock unit award vested on June 7, 2022 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |